Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
KD has bounced 6.6% on the week to $12.24, yet short interest remains near its highest level of the year and options traders continue to lean bullish, a tension that sharpens heading into November 4 earnings.
Short interest has eased slightly from its recent peak but remains elevated at 15.0% of free float, down a fraction from 15.1% the previous day but still up 10.8% on the week and 17.6% over the past month. That monthly build is the clearest signal of sustained bearish conviction. The ORTEX short score has been steady in the mid-60s all week, consistent with a deliberately held rather than panicked position. Borrowing costs ticked up 13% on the week to 0.48%, still low in absolute terms. Availability remains ample at 539%, roughly five shares available to borrow for every one already lent, so shorts face no structural pressure from the lending market. Days to cover at 8.3 means any covering would take time, which raises the stakes on the November print.
Options traders are not playing along with the bears. The put-call ratio has fallen further to 0.66, now 2.1 standard deviations below its 20-day mean of 0.72. That is among the most call-heavy readings KD has produced in recent months, and it has been sustained across three consecutive sessions this week rather than being a one-day anomaly. The divergence between rising short interest and bullish options flow, flagged in the previous note, has not resolved. Both sides are adding to their positions as the stock rallies.
The Street has not moved recently. The most recent analyst action of note was JP Morgan maintaining its Underweight rating in August while nudging its target from $13 to $14. The consensus mean target is $14.20, roughly 16% above current levels. Most coverage sits at neutral or below: Morgan Stanley holds Equal-Weight at $13, Susquehanna downgraded to Neutral in May, and BMO initiated at Market Perform with a $15 target in April. The bull case centres on margin recovery and stronger IT infrastructure demand, valued at roughly 4x revised FY27 adjusted EPS. Bears point to the material weakness in internal controls, multiple senior departures, and a revenue growth outlook that was cut sharply earlier this year. Valuation multiples have tightened modestly: the EV/EBITDA multiple has drifted up over the past month and the PE has compressed, reflecting the stock's own decline rather than estimate upgrades. The forward EPS momentum rank of 83 is a genuine positive, suggesting estimates are being revised upward even if the absolute level remains depressed.
AQR Capital Management has been the most active institutional buyer in recent filings, adding roughly 2.9 million shares to reach 6.7% of the company. D.E. Shaw and Two Sigma each built material new positions in the quarter to June, adding roughly 5.0 million and 1.96 million shares respectively. These are quant-driven buyers, and their presence alongside elevated short interest suggests the stock is attracting systematic attention from multiple directions. BlackRock remains the largest holder at 10.3%. No 13D activist is on the register; all large holders have filed passively.
Earnings history adds context. The August 2026 print sent the stock down 4.8% on the day and nearly 11% over the following five days. The prior print, in early August, produced an 8.4% gain on the day but gave it back entirely over the week. The pattern is volatile in both directions. With short interest at 15% of float and 8.3 days to cover, a positive surprise carries mechanical cover pressure; a miss would land in an already well-positioned short base.
ORTEX puts the probability of KD joining the Russell 2000 at the December 2026 Semi-Annual Review at 25%, with a corresponding 25% chance of leaving the Russell 1000. The stock would need to close above $14.01 to qualify for the Russell 2000 addition. An addition would require index trackers to buy approximately $394 million of stock, equivalent to 7.8 days of normal volume. The rank date is October 30 and the announcement date is November 13, which sits just after the earnings print on November 4 and could make the index outcome a secondary catalyst in the same window.
The next three weeks compress several catalysts into a short window: earnings on November 4, the Russell rank date on October 30, and the index announcement on November 13. How the short base responds to the earnings print, and whether the stock can hold above $14 into the rank date, are the two things worth watching.
See the live data behind this article on ORTEX.
Open KD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
